Effect of Proinflammatory Cytokines (IL-6, TNF-α, and IL-1β) on Clinical Manifestations in Indian SLE Patients. (7th December 2014)
- Record Type:
- Journal Article
- Title:
- Effect of Proinflammatory Cytokines (IL-6, TNF-α, and IL-1β) on Clinical Manifestations in Indian SLE Patients. (7th December 2014)
- Main Title:
- Effect of Proinflammatory Cytokines (IL-6, TNF-α, and IL-1β) on Clinical Manifestations in Indian SLE Patients
- Authors:
- Umare, Vinod
Pradhan, Vandana
Nadkar, Milind
Rajadhyaksha, Anjali
Patwardhan, Manisha
Ghosh, Kanjaksha K.
Nadkarni, Anita H. - Other Names:
- Petricevich Vera L. Academic Editor.
- Abstract:
- Abstract : Systemic lupus erythematosus (SLE) is an inflammatory rheumatic disease characterized by production of autoantibodies and organ damage. Elevated levels of cytokines have been reported in SLE patients. In this study we have investigated the effect of proinflammatory cytokines (IL-6, TNF- α, and IL-1 β ) on clinical manifestations in 145 Indian SLE patients. One hundred and forty-five healthy controls of the same ethnicity served as a control group. Clinical disease activity was scored according to SLEDAI score. Accordingly, 110 patients had active disease and 35 patients had inactive disease. Mean levels of IL-6, TNF- α, and IL-1 β were found to be significantly higher in SLE patients than healthy controls (P < 0.001 ). Mean level of IL-6 for patients with active disease (70.45 ± 68.32 pg/mL) was significantly higher (P = 0.0430 ) than those of inactive disease patients (43.85 ± 63.36 pg/mL). Mean level of TNF- α was 44.76 ± 68.32 pg/mL for patients with active disease while it was 25.97 ± 22.03 pg/mL for those with inactive disease and this difference was statistically significant (P = 0.0161 ). Similar results were obtained for IL-1 β (P = 0.0002 ). Correlation between IL-6, TNF- α, and IL-1 β serum levels and SLEDAI score was observed (r = 0.20, r = 0.27, and r = 0.38, resp.). This study supports the role of these proinflammatory cytokines as inflammatory mediators in active stage of disease.
- Is Part Of:
- Mediators of inflammation. Volume 2014(2014)
- Journal:
- Mediators of inflammation
- Issue:
- Volume 2014(2014)
- Issue Display:
- Volume 2014, Issue 2014 (2014)
- Year:
- 2014
- Volume:
- 2014
- Issue:
- 2014
- Issue Sort Value:
- 2014-2014-2014-0000
- Page Start:
- Page End:
- Publication Date:
- 2014-12-07
- Subjects:
- Inflammation -- Mediators -- Periodicals
Biological response modifiers -- Periodicals
Inflammation (Pathologie) -- Médiateurs
Immunomodulateurs
Biological response modifiers
Inflammation -- Mediators
Immunology
Autacoids
Immunologic Factors
Cell Adhesion Molecules
Cell Communication
Cytokines
Inflammation
Periodicals
Electronic journals
616.0473 - Journal URLs:
- https://www.hindawi.com/journals/mi/ ↗
- DOI:
- 10.1155/2014/385297 ↗
- Languages:
- English
- ISSNs:
- 0962-9351
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library HMNTS - ELD Digital store
- Ingest File:
- 23451.xml